Carbonic anhydrase

Contents

Carbonic anhydrase is a family of metalloenzymes that catalyze the reversible hydration of carbon dioxide to bicarbonate and protons. Discovered through biochemical studies intersecting the work of Linus Pauling, Antoine Lavoisier, Joseph Priestley, James Lovelock, and Sune Bergström, these enzymes became central to investigations by laboratories at institutions such as Harvard University, University of Cambridge, Max Planck Society, Massachusetts Institute of Technology, and Karolinska Institutet. Research on the family engaged influential scientists including Walther Nernst, August Kekulé, Emil Fischer, Arthur Harden, and Sydney Brenner.

Structure and Mechanism

The catalytic core is a conserved active site coordinating a zinc ion first detailed by structural studies at Royal Institution, Cold Spring Harbor Laboratory, European Molecular Biology Laboratory, and Brookhaven National Laboratory using methods pioneered at Bell Labs, Rutherford Appleton Laboratory, and Lawrence Berkeley National Laboratory. X-ray crystallography and cryo-EM investigations guided by protocols from Max Perutz and John Kendrew revealed a roughly 250–300 amino acid fold similar across mammalian and microbial forms, with active-site histidines modeled after works at University of Oxford and University of Edinburgh. Kinetic frameworks derived from collaborations between researchers at Stanford University, Johns Hopkins University, and University of Chicago applied Michaelis–Menten analysis and transition state theories developed by Victor Henri and Gustav Miechels, while computational chemistry groups at ETH Zurich and California Institute of Technology used quantum mechanics/molecular mechanics (QM/MM) approaches informed by Linus Pauling and John Pople to elucidate proton transfer pathways. Mechanistically, catalysis involves nucleophilic attack of zinc-bound hydroxide on CO2, with proton shuttling mediated by histidine residues analogous to mechanisms studied by labs at University of Michigan and University of California, San Francisco.

Isoforms occur across Bacteria, Archaea, and Eukarya, with notable families first cataloged by taxonomists at Smithsonian Institution and sequence analysts at National Institutes of Health. Mammalian isoforms (e.g., cytosolic, mitochondrial, membrane-bound, secreted) were characterized in surveys led by Karolinska Institutet and Imperial College London and mapped in atlases created by The Human Protein Atlas and consortiums at European Bioinformatics Institute. Tissue-specific expression studies from Massachusetts General Hospital, Cleveland Clinic, and Mayo Clinic documented high abundance in kidney, erythrocytes, eye, brain, and gastrointestinal epithelia, with distinct subcellular targeting signals analogous to trafficking research at Cold Spring Harbor Laboratory and Scripps Research. Comparative genomics projects at Broad Institute and Wellcome Sanger Institute expanded isoform catalogs across model organisms used at The Jackson Laboratory and Max Delbrück Center for Molecular Medicine.

Enzymatic activity underpins processes central to respiration and acid–base balance, topics studied in classic physiology laboratories at University College London, Guy's Hospital, and Johns Hopkins Hospital. In blood, erythrocyte-associated isoforms facilitate CO2 transport studied in clinical trials run by teams at Mayo Clinic, Cleveland Clinic, and Mount Sinai Hospital; in kidney, tubular isoforms support bicarbonate reabsorption investigated by nephrology groups at Beth Israel Deaconess Medical Center and Massachusetts General Hospital. In ocular physiology, roles in aqueous humor production were explored by researchers at Moorfields Eye Hospital and Bascom Palmer Eye Institute, while neuronal expression and pH regulation were examined in neuroscience departments at University of California, Los Angeles and Columbia University. Roles in calcification, bone remodeling, and fertilization were assessed by reproductive biology units at University of Copenhagen and University of Melbourne.

Dysfunction or altered expression links to conditions investigated in clinical centers like Cleveland Clinic, Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital. Mutations causing inherited enzyme deficiencies were identified in patient cohorts assembled by genetics teams at Broad Institute and Wellcome Sanger Institute, correlating with metabolic acidosis, osteopetrosis, and visual impairment cases recorded at Great Ormond Street Hospital and St Thomas' Hospital. Overexpression in tumors has been documented in oncology groups at Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, and MD Anderson Cancer Center, where isoforms contribute to tumor microenvironment acidification studied alongside hypoxia research from National Cancer Institute and European Organization for Research and Treatment of Cancer. Pathogen-derived isoforms were characterized by infectious disease labs at Pasteur Institute, Robert Koch Institute, and Centers for Disease Control and Prevention for roles in bacterial virulence and protozoan survival.

Sulfonamides and related chemotypes emerged from medicinal chemistry efforts at AstraZeneca, Pfizer, and GlaxoSmithKline and were refined through collaborations with academic groups at University of Cambridge and King's College London. Clinical applications include diuretics, antiglaucoma agents, anticonvulsants, and adjuncts in oncology trials run at Mayo Clinic, Johns Hopkins Hospital, and MD Anderson Cancer Center. Drug discovery pipelines at Novartis, Roche, and Bayer leveraged high-throughput screening platforms developed at EMBL-EBI and Broad Institute to identify isoform-selective inhibitors, while structural teams at European Synchrotron Radiation Facility and Diamond Light Source guided lead optimization. Natural product inhibitors from marine bioprospecting programs at Scripps Institution of Oceanography and Woods Hole Oceanographic Institution provided alternative scaffolds for anti-infective research coordinated with Wellcome Trust funding.

Phylogenetic reconstructions by evolutionary biologists at University of California, Berkeley, Harvard University, and University of Toronto placed diverse families into convergent clades, reflecting lateral gene transfer events cataloged by computational groups at European Bioinformatics Institute and Broad Institute. Gene duplication and subfunctionalization models developed in labs at Stanford University and University of Chicago explain mammalian isoform diversity, while transcriptomic atlases from ENCODE and GTEx projects detailed regulatory landscapes for CA genes. Molecular cloning and expression systems refined at Addgene and Thermo Fisher Scientific enabled recombinant studies, and genome editing techniques from Broad Institute and CRISPR Therapeutics facilitated functional dissection in model organisms maintained at The Jackson Laboratory and European Mouse Mutant Archive.

Category:Enzymes